摩根士丹利发表研究报告指，将威高股份(01066.HK) 2026至28年的收入预测下调1至2%，以反映常规耗材业务持续面对带量采购(VBP)及竞争的逆风，以及近期政策对骨科业务的影响，预计整体收入仅录得低单数增长。大摩将威高股份2026至28年的每股盈测分别下调11.8%、12.6%及13.5%，目标价由5.2元下调至4.5元，续予“与大市同步”评级。(sl/da)(港股报价延迟最少十五分钟。...
Source Link摩根士丹利发表研究报告指，将威高股份(01066.HK) 2026至28年的收入预测下调1至2%，以反映常规耗材业务持续面对带量采购(VBP)及竞争的逆风，以及近期政策对骨科业务的影响，预计整体收入仅录得低单数增长。大摩将威高股份2026至28年的每股盈测分别下调11.8%、12.6%及13.5%，目标价由5.2元下调至4.5元，续予“与大市同步”评级。(sl/da)(港股报价延迟最少十五分钟。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.